Differentiating Sirolimus and Everolimus in Combination With Calcineurin Inhibitors in Long-term Maintenance of Kidney Transplant Patients - The Effects on Vascular Endothelial and Kidney Function. The DESIRE Study.
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2015
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Sirolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Biomarker; Pharmacodynamics
- Acronyms DESIRE
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2014 Status changed from recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
- 17 Mar 2014 New trial record